Outcomes in patients with acute and stable coronary syndromes; insights from the prospective NOBORI-2 study.
Contemporary data remains limited regarding mortality and major adverse cardiac events (MACE) outcomes in patients undergoing PCI for different manifestations of coronary artery disease.We evaluated mortality and MACE outcomes in patients treated with PCI for STEMI (ST-elevation myocardial infarctio...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC3925145?pdf=render |
| _version_ | 1818940498620973056 |
|---|---|
| author | Farzin Fath-Ordoubadi Erik Spaepen Magdi El-Omar Douglas G Fraser Muhammad A Khan Ludwig Neyses Gian B Danzi Ariel Roguin Dragica Paunovic Mamas A Mamas |
| author_facet | Farzin Fath-Ordoubadi Erik Spaepen Magdi El-Omar Douglas G Fraser Muhammad A Khan Ludwig Neyses Gian B Danzi Ariel Roguin Dragica Paunovic Mamas A Mamas |
| author_sort | Farzin Fath-Ordoubadi |
| collection | DOAJ |
| description | Contemporary data remains limited regarding mortality and major adverse cardiac events (MACE) outcomes in patients undergoing PCI for different manifestations of coronary artery disease.We evaluated mortality and MACE outcomes in patients treated with PCI for STEMI (ST-elevation myocardial infarction), NSTEMI (non ST-elevation myocardial infarction) and stable angina through analysis of data derived from the Nobori-2 study.Clinical endpoints were cardiac mortality and MACE (a composite of cardiac death, myocardial infarction and target vessel revascularization).1909 patients who underwent PCI were studied; 1332 with stable angina, 248 with STEMI and 329 with NSTEMI. Age-adjusted Charlson co-morbidity index was greatest in the NSTEMI cohort (3.78±1.91) and lowest in the stable angina cohort (3.00±1.69); P<0.0001. Following Cox multivariate analysis cardiac mortality was independently worse in the NSTEMI vs the stable angina cohort (HR 2.31 (1.10-4.87), p = 0.028) but not significantly different for STEMI vs stable angina cohort (HR 0.72 (0.16-3.19), p = 0.67). Similar observations were recorded for MACE (<180 days) (NSTEMI vs stable angina: HR 2.34 (1.21-4.55), p = 0.012; STEMI vs stable angina: HR 2.19 (0.97-4.98), p = 0.061.The longer-term Cardiac mortality and MACE were significantly worse for patients following PCI for NSTEMI even after adjustment of clinical demographics and Charlson co-morbidity index whilst the longer-term prognosis of patients following PCI STEMI was favorable, with similar outcomes as those patients with stable angina following PCI. |
| first_indexed | 2024-12-20T06:40:36Z |
| format | Article |
| id | doaj.art-4e46508f627044e5ad1f34123b674676 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-20T06:40:36Z |
| publishDate | 2014-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-4e46508f627044e5ad1f34123b6746762022-12-21T19:49:51ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0192e8857710.1371/journal.pone.0088577Outcomes in patients with acute and stable coronary syndromes; insights from the prospective NOBORI-2 study.Farzin Fath-OrdoubadiErik SpaepenMagdi El-OmarDouglas G FraserMuhammad A KhanLudwig NeysesGian B DanziAriel RoguinDragica PaunovicMamas A MamasContemporary data remains limited regarding mortality and major adverse cardiac events (MACE) outcomes in patients undergoing PCI for different manifestations of coronary artery disease.We evaluated mortality and MACE outcomes in patients treated with PCI for STEMI (ST-elevation myocardial infarction), NSTEMI (non ST-elevation myocardial infarction) and stable angina through analysis of data derived from the Nobori-2 study.Clinical endpoints were cardiac mortality and MACE (a composite of cardiac death, myocardial infarction and target vessel revascularization).1909 patients who underwent PCI were studied; 1332 with stable angina, 248 with STEMI and 329 with NSTEMI. Age-adjusted Charlson co-morbidity index was greatest in the NSTEMI cohort (3.78±1.91) and lowest in the stable angina cohort (3.00±1.69); P<0.0001. Following Cox multivariate analysis cardiac mortality was independently worse in the NSTEMI vs the stable angina cohort (HR 2.31 (1.10-4.87), p = 0.028) but not significantly different for STEMI vs stable angina cohort (HR 0.72 (0.16-3.19), p = 0.67). Similar observations were recorded for MACE (<180 days) (NSTEMI vs stable angina: HR 2.34 (1.21-4.55), p = 0.012; STEMI vs stable angina: HR 2.19 (0.97-4.98), p = 0.061.The longer-term Cardiac mortality and MACE were significantly worse for patients following PCI for NSTEMI even after adjustment of clinical demographics and Charlson co-morbidity index whilst the longer-term prognosis of patients following PCI STEMI was favorable, with similar outcomes as those patients with stable angina following PCI.http://europepmc.org/articles/PMC3925145?pdf=render |
| spellingShingle | Farzin Fath-Ordoubadi Erik Spaepen Magdi El-Omar Douglas G Fraser Muhammad A Khan Ludwig Neyses Gian B Danzi Ariel Roguin Dragica Paunovic Mamas A Mamas Outcomes in patients with acute and stable coronary syndromes; insights from the prospective NOBORI-2 study. PLoS ONE |
| title | Outcomes in patients with acute and stable coronary syndromes; insights from the prospective NOBORI-2 study. |
| title_full | Outcomes in patients with acute and stable coronary syndromes; insights from the prospective NOBORI-2 study. |
| title_fullStr | Outcomes in patients with acute and stable coronary syndromes; insights from the prospective NOBORI-2 study. |
| title_full_unstemmed | Outcomes in patients with acute and stable coronary syndromes; insights from the prospective NOBORI-2 study. |
| title_short | Outcomes in patients with acute and stable coronary syndromes; insights from the prospective NOBORI-2 study. |
| title_sort | outcomes in patients with acute and stable coronary syndromes insights from the prospective nobori 2 study |
| url | http://europepmc.org/articles/PMC3925145?pdf=render |
| work_keys_str_mv | AT farzinfathordoubadi outcomesinpatientswithacuteandstablecoronarysyndromesinsightsfromtheprospectivenobori2study AT erikspaepen outcomesinpatientswithacuteandstablecoronarysyndromesinsightsfromtheprospectivenobori2study AT magdielomar outcomesinpatientswithacuteandstablecoronarysyndromesinsightsfromtheprospectivenobori2study AT douglasgfraser outcomesinpatientswithacuteandstablecoronarysyndromesinsightsfromtheprospectivenobori2study AT muhammadakhan outcomesinpatientswithacuteandstablecoronarysyndromesinsightsfromtheprospectivenobori2study AT ludwigneyses outcomesinpatientswithacuteandstablecoronarysyndromesinsightsfromtheprospectivenobori2study AT gianbdanzi outcomesinpatientswithacuteandstablecoronarysyndromesinsightsfromtheprospectivenobori2study AT arielroguin outcomesinpatientswithacuteandstablecoronarysyndromesinsightsfromtheprospectivenobori2study AT dragicapaunovic outcomesinpatientswithacuteandstablecoronarysyndromesinsightsfromtheprospectivenobori2study AT mamasamamas outcomesinpatientswithacuteandstablecoronarysyndromesinsightsfromtheprospectivenobori2study |